We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-12.82%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.1B
AUM Growth
-$431M
Cap. Flow
-$207M
Cap. Flow %
-18.91%
Top 10 Hldgs %
47.26%
Holding
290
New
16
Increased
77
Reduced
109
Closed
55

Sector Composition

Rank Sector Weight
1 Technology 11.93%
2 Healthcare 9.6%
3 Industrials 5.18%
4 Financials 4.95%
5 Consumer Discretionary 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUB icon
201
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$226K 0.02%
2,128
RDS.A
202
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$226K 0.02%
6,489
-164
-2% -$7.66K
LUMN icon
203
Lumen
LUMN
$6.57B
$222K 0.02%
23,479
+42
+0.2% +$525
AMT icon
204
American Tower
AMT
$80.8B
$221K 0.02%
+1,017
New +$237K
VEU icon
205
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$220K 0.02%
5,365
-744
-12% -$36.6K
AZN icon
206
AstraZeneca
AZN
$263B
$216K 0.02%
2,422
-497
-17% -$46.8K
SCHB icon
207
Schwab US Broad Market ETF
SCHB
$43.2B
$216K 0.02%
21,438
+6
+0% +$73
GPC icon
208
Genuine Parts
GPC
$17.1B
$208K 0.02%
3,084
TRV icon
209
Travelers Companies
TRV
$78.1B
$208K 0.02%
2,097
-21
-1% -$2.61K
IRWD icon
210
Ironwood Pharmaceuticals
IRWD
$696M
$173K 0.02%
17,100
INVA icon
211
Innoviva
INVA
$1.55B
$151K 0.01%
12,800
-400
-3% -$5.29K
PBYI icon
212
Puma Biotechnology
PBYI
$404M
$135K 0.01%
16,000
-300
-2% -$2.92K
MJ icon
213
Amplify Alternative Harvest ETF
MJ
$101M
$117K 0.01%
+856
New +$152K
CALA
214
DELISTED
Calithera Biosciences, Inc
CALA
$112K 0.01%
1,265
NAK
215
Northern Dynasty Minerals
NAK
$784M
$105K 0.01%
272,215
HBAN icon
216
Huntington Bancshares
HBAN
$34.4B
$104K 0.01%
12,723
-108,127
-89% -$1.33M
RF icon
217
Regions Financial
RF
$26.4B
$103K 0.01%
11,502
-95
-0.8% -$1.33K
LJPC
218
DELISTED
La Jolla Pharmaceutical Company
LJPC
$99K 0.01%
23,500
-1,000
-4% -$6.32K
VBIV
219
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$96K 0.01%
3,371
+714
+27% +$27.8K
F icon
220
Ford
F
$58.5B
$51K ﹤0.01%
10,497
-19,045
-64% -$143K
ASX icon
221
ASE Group
ASX
$77.3B
$44K ﹤0.01%
11,686
-1,342
-10% -$6.29K
GNW icon
222
Genworth Financial
GNW
$3.76B
$44K ﹤0.01%
13,225
AGRX
223
DELISTED
Agile Therapeutics
AGRX
$37K ﹤0.01%
10
LYG icon
224
Lloyds Banking Group
LYG
$89.5B
$35K ﹤0.01%
+23,301
New +$60.1K
RBBN icon
225
Ribbon Communications
RBBN
$377M
$30K ﹤0.01%
+10,030
New +$30.1K

Similar funds

Grimes & Company's Q1 2020 Portfolio in Review

As of Q1 2020, Grimes & Company held 290 positions worth $1.1B, down 28% from $1.53B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Grimes & Company withdrew a net $207M in Q1 2020, closing 55 positions and reducing 109 holdings. Its most notable exit was iShares Preferred and Income Securities ETF, an estimated $74.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Grimes & Company opened a new position in iShares 0-1 Year Treasury Bond ETF worth $146M.

  • Grimes & Company's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 1,316,124 shares worth $146M.
  • Grimes & Company added most to iShares Core US Aggregate Bond ETF in Q1 2020, an estimated $73.1M increase.
  • Grimes & Company's biggest Q1 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $52.2M.
  • Grimes & Company fully exited iShares Preferred and Income Securities ETF in Q1 2020, selling an estimated $74.5M.
  • Grimes & Company's ten largest holdings make up 47% of its $1.1B portfolio in Q1 2020.
  • Grimes & Company opened 16 new positions and closed 55 in Q1 2020.
  • Grimes & Company's portfolio value fell 28% quarter-over-quarter to $1.1B.

Based on Grimes & Company's 13F filing for Q1 2020, filed 5 May 2020.